Clinical Edge Journal Scan

Increased prevalence of allergic contact dermatitis in patients with atopic dermatitis


 

Key clinical point: After patch testing, the frequency of allergic contact dermatitis (ACD) diagnosis was higher among patients with atopic dermatitis (AD) than among individuals without AD.

Major finding: Among patients with AD vs individuals without AD, the diagnosis rate of ACD (54.8% vs 47.3%; P < .0001), particularly ACD to cosmetics (7.0% vs 5.7%; P = .0007), medicaments (2.3% vs 1.7%; P = .02), dyes (1.9% vs 1.4%; P = .036), and foods contacting the skin (0.4% vs 0.1%; P = .003), was significantly higher.

Study details: This retrospective study included 15,737 individuals who underwent patch testing, of which 5641 were diagnosed with AD.

Disclosures: This study did not receive any funding. The authors declared no conflicts of interest.

Source: Qian MF et al. Prevalence of allergic contact dermatitis following patch testing in patients with atopic dermatitis: A retrospective United States claims-based study. J Am Acad Dermatol. 2023 (Feb 10). Doi: 10.1016/j.jaad.2022.12.051

Recommended Reading

Atopic dermatitis increases the risk for food allergy, food sensitivity, challenge-proven food allergy, and vice versa
MDedge Dermatology
Commentary: Sorting out useful atopic dermatitis research from filler, March 2023
MDedge Dermatology
How to help pediatricians apply peanut allergy guidelines
MDedge Dermatology
Dermatologic Implications of Sleep Deprivation in the US Military
MDedge Dermatology
Cyclosporine-Induced Posterior Reversible Encephalopathy Syndrome: An Adverse Effect in a Patient With Atopic Dermatitis
MDedge Dermatology
Lebrikizumab monotherapy for AD found safe, effective during induction
MDedge Dermatology
Study finds quality of topical steroid withdrawal videos on YouTube subpar
MDedge Dermatology
JAK inhibitor safety warnings drawn from rheumatologic data may be misleading in dermatology
MDedge Dermatology
Dupilumab safe and effective in the elderly with moderate-to-severe atopic dermatitis
MDedge Dermatology
Upadacitinib effective for moderate-to-severe atopic dermatitis in daily practice
MDedge Dermatology